MAPK1 and melanoma: MAP2K2 plays a key role in the signal transduction of mitogen growth factor.[36] MAP2K2 has gain-of-function mutations in melanomas, leading to constitutive ERK phosphorylation and higher resistance to MEK inhibitors.